Deciphering the role of IL-36 in psoriasis

被引：0

作者：

Witte, E. ^{[1
]}

Doecke, W. -D. ^{[2
]}

Ramm, M. ^{[1
]}

Schmidt, N. ^{[2
]}

Jodl, S. ^{[2
]}

Volk, H. -D. ^{[3
,4
]}

Sterry, W. ^{[5
]}

Wolk, K. ^{[1
]}

Sabat, R. ^{[1
,6
]}

机构：

[1] Univ Hosp Charite, Psoriasis Res & Treatment Ctr, Dermatol Med Immunol, Berlin, Germany

[2] Bayer Pharma AG, Berlin, Germany

[3] Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany

[4] Inst Med Immunol, Berlin, Germany

[5] Dept Dermatol & Allergy, Berlin, Germany

[6] Univ Hosp Charite, Res Ctr Immunosci, Berlin, Germany

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2016年 / 30卷

关键词：

deep sequencing analysis; IL-1 cytokine family; lipocalin; 2;

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P116

引用

页码：57 / 57

页数：1

共 50 条

[31] Serum IL-36α, IL-36β, and IL-36γ levels in patients with hidradenitis suppurativa: association with disease characteristics, smoking, obesity, and metabolic syndrome
Y. Hayran
N. Allı
Ç. Yücel
N. Akdoğan
T. Turhan
Archives of Dermatological Research, 2020, 312 : 187 - 196
[32] Role of IL-36 in acute generalized exanthematous pustulosis
Meier, B.
Mellett, M.
Feldmeyer, L.
Jankovic, D.
Navarini, A.
Contassot, E.
French, L. E.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (09) : B17 - B17
[33] The Role of IL-36 in the Pathophysiological Processes of Autoimmune Diseases
Chen, Wen-jian
Yu, Xiao
Yuan, Xin-Rong
Chen, Bang-jie
Cai, Na
Zeng, Shuo
Sun, Yuan-song
Li, Hai-wen
FRONTIERS IN PHARMACOLOGY, 2021, 12
[34] Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque Psoriasis
Todorovic, Viktor
Su, Zhi
Putman, C. Brent
Kakavas, Stevan J.
Salte, Katherine M.
McDonald, Heath A.
Wetter, Joseph B.
Paulsboe, Stephanie E.
Sun, Qi
Gerstein, Clare E.
Medina, Limary
Sielaff, Bernhard
Sadhukhan, Ramkrishna
Stockmann, Henning
Richardson, Paul L.
Qiu, Wei
Argiriadi, Maria A.
Henry, Rodger F.
Herold, J. Martin
Shotwell, J. Brad
McGaraughty, Steve P.
Honore, Prisca
Gopalakrishnan, Sujatha M.
Sun, Chaohong C.
Scott, Victoria E.
SCIENTIFIC REPORTS, 2019, 9 (1)
[35] IL-36 SIGNALING IN KERATINOCYTES IS MANDATORY IN IMIQUIMOD-INDUCED PSORIASIS IN MICE
Goldstein, J.
Bassoy, E. Y.
Palomo, J.
Rodriguez, E.
Gabay, C.
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : A40 - A41
[36] IL-36 stimulates Th1 responses and is implicated in human psoriasis
Sims, J.
CYTOKINE, 2012, 59 (03) : 492 - 492
[37] Soluble Interleukin-36 receptor antagonizes IL-36/IL-36R signaling to control skin inflammation in psoriasis
Wang, W.
Lai, Y.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 782 - 783
[38] Soluble Interleukin-36 receptor antagonizes IL-36/IL-36R signaling to control skin inflammation in psoriasis
Wang, W.
Lai, Y.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S80 - S80
[39] Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque Psoriasis
Viktor Todorović
Zhi Su
C. Brent Putman
Stevan J. Kakavas
Katherine M. Salte
Heath A. McDonald
Joseph B. Wetter
Stephanie E. Paulsboe
Qi Sun
Clare E. Gerstein
Limary Medina
Bernhard Sielaff
Ramkrishna Sadhukhan
Henning Stockmann
Paul L. Richardson
Wei Qiu
Maria A. Argiriadi
Rodger F. Henry
J. Martin Herold
J. Brad Shotwell
Steve P. McGaraughty
Prisca Honore
Sujatha M. Gopalakrishnan
Chaohong C. Sun
Victoria E. Scott
Scientific Reports, 9
[40] Generalized pustular psoriasis: the new era of treatment with IL-36 receptor inhibitors
Macaes, Claudia Oliveira
Le, Ana Maria
Torres, Tiago
JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (07) : 2911 - 2918

← 1 2 3 4 5 →